Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ER+ HER2- Advanced Breast Cancer × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Gynecologic 1

Conditions

Ovarian Neoplasms 2832 Uterine Cervical Neoplasms 1910 Endometrial Neoplasms 1172 Fallopian Tube Neoplasms 730 Breast Neoplasms 719 Carcinoma, Ovarian Epithelial 697 Neoplasms 468 Colorectal Neoplasms 378 Carcinoma, Non-Small-Cell Lung 367 Uterine Cervical Dysplasia 325 Pancreatic Neoplasms 317 Stomach Neoplasms 309 Prostatic Neoplasms 275 Lung Neoplasms 271 Melanoma 252 Peritoneal Neoplasms 210 Uterine Neoplasms 209 Vulvar Neoplasms 208 Urinary Bladder Neoplasms 203 Esophageal Neoplasms 199 Neoplasm Metastasis 198 Head and Neck Neoplasms 195 Sarcoma 193 Recurrence 184 Papillomavirus Infections 183 Colonic Neoplasms 179 Carcinoma, Renal Cell 177 Triple Negative Breast Neoplasms 162 Squamous Cell Carcinoma of Head and Neck 156 Vaginal Neoplasms 132

Interventions

ribociclib 1 palbociclib 1 abemaciclib 1 AZD9833 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06188520 2026-02-24

CYCAD-1

AstraZeneca

Phase 1/2 Recruiting

BreastGynecologic

ER+ HER2- Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡